ES2306459T3 - Prevencion y tratamiento de adenoma colonico o microadenoma colonico mediante acido 6-fluoroursodesoxicolico (6-fudca). - Google Patents
Prevencion y tratamiento de adenoma colonico o microadenoma colonico mediante acido 6-fluoroursodesoxicolico (6-fudca). Download PDFInfo
- Publication number
- ES2306459T3 ES2306459T3 ES97925934T ES97925934T ES2306459T3 ES 2306459 T3 ES2306459 T3 ES 2306459T3 ES 97925934 T ES97925934 T ES 97925934T ES 97925934 T ES97925934 T ES 97925934T ES 2306459 T3 ES2306459 T3 ES 2306459T3
- Authority
- ES
- Spain
- Prior art keywords
- fudca
- colonic
- acid
- prevention
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US1820296P | 1996-05-23 | 1996-05-23 | |
| US18202P | 1996-05-23 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2306459T3 true ES2306459T3 (es) | 2008-11-01 |
Family
ID=21786767
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES97925934T Expired - Lifetime ES2306459T3 (es) | 1996-05-23 | 1997-05-22 | Prevencion y tratamiento de adenoma colonico o microadenoma colonico mediante acido 6-fluoroursodesoxicolico (6-fudca). |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US6426340B1 (show.php) |
| EP (1) | EP0906106B1 (show.php) |
| JP (2) | JP2000510858A (show.php) |
| AT (1) | ATE394107T1 (show.php) |
| AU (1) | AU3091597A (show.php) |
| CA (1) | CA2253593C (show.php) |
| DE (1) | DE69738667D1 (show.php) |
| ES (1) | ES2306459T3 (show.php) |
| PT (1) | PT906106E (show.php) |
| WO (1) | WO1997044043A1 (show.php) |
Families Citing this family (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2000004875A2 (en) * | 1998-07-24 | 2000-02-03 | Seo Hong Yoo | Preparation of aqueous clear solution dosage forms with bile acids |
| JP2002522381A (ja) * | 1998-08-06 | 2002-07-23 | ストレンメル，ボルフガング | 粘膜保護用医薬としてのホスファチジルコリン |
| MXPA02003321A (es) * | 1999-09-28 | 2004-09-10 | Panacea Biotec Ltd | Composiciones de liberacion controlada que comprenden nimesulida. |
| US7053076B2 (en) | 2001-08-29 | 2006-05-30 | Xenoport, Inc. | Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs |
| CA2503811A1 (en) * | 2002-11-01 | 2004-05-21 | James Kaput | Identification of diet-regulated disease-associated genes |
| US20090074785A1 (en) * | 2007-01-16 | 2009-03-19 | Smith Jeffrey W | Compositions and methods for treatment of colorectal cancer |
| EP2255813A1 (en) * | 2009-05-29 | 2010-12-01 | The Royal College of Surgeons in Ireland | Derivatives of ursodeoxycholic acid for the treatment of diarrhoea |
| ES2687027T3 (es) | 2010-11-04 | 2018-10-23 | Albireo Ab | Inhibidores de ibat para el tratamiento de enfermedades hepáticas |
| KR102560954B1 (ko) | 2014-06-25 | 2023-07-31 | 이에이 파마 가부시키가이샤 | 고형 제제 및 그의 착색 방지 또는 착색 감소 방법 |
| US10441604B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Cholestyramine pellets and methods for preparation thereof |
| US10786529B2 (en) | 2016-02-09 | 2020-09-29 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10441605B2 (en) | 2016-02-09 | 2019-10-15 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| EP3664781A1 (en) | 2017-08-09 | 2020-06-17 | Albireo AB | Cholestyramine granules, oral cholestyramine formulations and use thereof |
| WO2019234077A1 (en) | 2018-06-05 | 2019-12-12 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| US10793534B2 (en) | 2018-06-05 | 2020-10-06 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| CA3100687A1 (en) | 2018-06-20 | 2019-12-26 | Albireo Ab | Pharmaceutical formulation of odevixibat |
| US11801226B2 (en) | 2018-06-20 | 2023-10-31 | Albireo Ab | Pharmaceutical formulation of odevixibat |
| GB201812382D0 (en) | 2018-07-30 | 2018-09-12 | Nzp Uk Ltd | Compounds |
| US11007142B2 (en) | 2018-08-09 | 2021-05-18 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US10722457B2 (en) | 2018-08-09 | 2020-07-28 | Albireo Ab | Oral cholestyramine formulation and use thereof |
| US11549878B2 (en) | 2018-08-09 | 2023-01-10 | Albireo Ab | In vitro method for determining the adsorbing capacity of an insoluble adsorbant |
| CR20210458A (es) | 2019-02-06 | 2021-11-04 | Albireo Ab | Compuestos de benzotiadiazepina y su uso como moduladores del ácido biliar |
| US10975045B2 (en) | 2019-02-06 | 2021-04-13 | Aibireo AB | Benzothiazepine compounds and their use as bile acid modulators |
| US10941127B2 (en) | 2019-02-06 | 2021-03-09 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
| ES3029063T3 (en) | 2019-12-04 | 2025-06-23 | Albireo Ab | Benzothiadiazepine compounds and their use as bile acid modulators |
| JP7696897B2 (ja) | 2019-12-04 | 2025-06-23 | アルビレオ・アクチボラグ | ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
| JP7696898B2 (ja) | 2019-12-04 | 2025-06-23 | アルビレオ・アクチボラグ | ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用 |
| US11014898B1 (en) | 2020-12-04 | 2021-05-25 | Albireo Ab | Benzothiazepine compounds and their use as bile acid modulators |
| DK4069360T3 (da) | 2019-12-04 | 2024-02-26 | Albireo Ab | Benzothia(di)azepinforbindelser og anvendelse deraf som galdesyremodulatorer |
| EP4188541B1 (en) | 2020-08-03 | 2024-12-25 | Albireo AB | Benzothia(di)azepine compounds and their use as bile acid modulators |
| KR20230106651A (ko) | 2020-11-12 | 2023-07-13 | 알비레오 에이비 | 진행성 가족성 간내 담즙정체증(pfic)을 치료하기 위한 오데빅시바트 |
| AU2021390172A1 (en) | 2020-12-04 | 2023-06-22 | Albireo Ab | Benzothia(di)azepine compounds and their use as bile acid modulators |
| TW202313579A (zh) | 2021-06-03 | 2023-04-01 | 瑞典商艾爾比瑞歐公司 | 苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8825526D0 (en) * | 1988-11-01 | 1988-12-07 | Enzymatix Ltd | Diagnosis |
| US5175320A (en) * | 1989-04-17 | 1992-12-29 | Giuliani S.P.A. | Fluorinated bile acid derivatives, processes for the preparation thereof and pharmaceutical compositions containing them |
| US5843929A (en) | 1996-03-22 | 1998-12-01 | Mayo Foundation For Medical Education And Research | Chemoprevention of metachronous adenomatous colorectal polyps |
-
1997
- 1997-05-22 ES ES97925934T patent/ES2306459T3/es not_active Expired - Lifetime
- 1997-05-22 DE DE69738667T patent/DE69738667D1/de not_active Expired - Lifetime
- 1997-05-22 AU AU30915/97A patent/AU3091597A/en not_active Abandoned
- 1997-05-22 PT PT97925934T patent/PT906106E/pt unknown
- 1997-05-22 CA CA002253593A patent/CA2253593C/en not_active Expired - Fee Related
- 1997-05-22 EP EP97925934A patent/EP0906106B1/en not_active Expired - Lifetime
- 1997-05-22 JP JP09541562A patent/JP2000510858A/ja active Pending
- 1997-05-22 WO PCT/EP1997/002632 patent/WO1997044043A1/en not_active Ceased
- 1997-05-22 AT AT97925934T patent/ATE394107T1/de not_active IP Right Cessation
-
2000
- 2000-10-06 US US09/684,585 patent/US6426340B1/en not_active Expired - Fee Related
-
2009
- 2009-11-02 JP JP2009252071A patent/JP2010059175A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP2010059175A (ja) | 2010-03-18 |
| EP0906106A1 (en) | 1999-04-07 |
| DE69738667D1 (de) | 2008-06-19 |
| PT906106E (pt) | 2008-08-07 |
| CA2253593C (en) | 2008-07-08 |
| EP0906106B1 (en) | 2008-05-07 |
| US6426340B1 (en) | 2002-07-30 |
| CA2253593A1 (en) | 1997-11-27 |
| AU3091597A (en) | 1997-12-09 |
| JP2000510858A (ja) | 2000-08-22 |
| ATE394107T1 (de) | 2008-05-15 |
| WO1997044043A1 (en) | 1997-11-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2306459T3 (es) | Prevencion y tratamiento de adenoma colonico o microadenoma colonico mediante acido 6-fluoroursodesoxicolico (6-fudca). | |
| Halsted et al. | Distribution of ethanol in the human gastrointestinal tract | |
| ES2962302T3 (es) | Tratamiento de la colestasis intrahepática y hepatopatías relacionadas | |
| JP4790123B2 (ja) | 胆汁酸を有する透明水溶液型製剤の調剤 | |
| KR100848344B1 (ko) | 담즙산 함유 청정 수용액 제형의 제조 | |
| JP3260378B2 (ja) | 腸感染に対する薬物の調製のためのフマギロールおよびその誘導体の使用 | |
| Koppisetti et al. | Reactive oxygen species and the hypomotility of the gall bladder as targets for the treatment of gallstones with melatonin: a review | |
| Resnick et al. | Chemical and histologic demonstration of hydrochloric acid-induced release of serotonin from intestinal mucosa | |
| JPH07508013A (ja) | 医薬物用吸収促進剤としてのノルおよびホモ胆汁酸誘導体の使用 | |
| RU94027277A (ru) | Препараты ризедроната с замедленным выделением, способ лечения | |
| JP2002522357A5 (show.php) | ||
| PT1919458E (pt) | Cisteamina revestida entericamente, cisteamina e seus derivados | |
| JP2000507938A (ja) | 結腸直腸の化学的保護のためのウルソデオキシコール酸化合物及びｎｓａｉｄの組合せ | |
| JPH09503776A (ja) | 医療に使用する化合物 | |
| ES2288847T3 (es) | Uso de inhibidores de endotoxina para el tratamiento de la caquexia. | |
| KR100450293B1 (ko) | 만성장염의치료에유용한알카노일l-카르니틴의용도 | |
| JPH04230223A (ja) | ソマトスタチン吸収改善医薬組成物、その製法および用途 | |
| NO332773B1 (no) | Anvendelse av epotilon B og farmasoytisk preparat inneholdende en slik forbindelse | |
| Meeberg et al. | Therapy with ursodeoxycholic acid in cholestatic liver disease | |
| JP2007528361A (ja) | 前立腺障害の治療および予防のための生薬組成物 | |
| Macaluso et al. | The METEOR trial: the burial of methotrexate in ulcerative colitis? | |
| JPH0224250B2 (show.php) | ||
| Allen et al. | Chemical dissolution of bile duct stones | |
| WO1993001817A1 (en) | Antiviral compositions comprising fusidic acid, l-ascorbic acid and salicylic acid and derivatives | |
| US6677328B1 (en) | Method for the prevention of colonic adenomas |